Delivery Order SPE2DR25D2012-SPE2DR26F1BHW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Twinrix vaccine in syringe format, with a ceiling value of $1,057.11 and an ultimate completion date of September 19, 2025. This is a firm fixed-price, non-set-aside contract, representing a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Twinrix vaccine in syringe format, with a ceiling value of $2,106.79. This is a firm fixed-price delivery order with an ultimate completion date of July 11, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The award carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Twinrix vaccine in syringe form. This firm fixed price delivery order, valued at $1,260.05, represents a non-competitive award issued under an existing contract vehicle and is scheduled for completion by September 24, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Twinrix vaccine in syringe form, with a contract value of $2,184.12 and an ultimate completion date of July 31, 2025. This non-set-aside contract utilizes firm fixed price pricing and is classified as a delivery order under the company's existing indefinite delivery contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $13,811.09 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Twinrix vaccine in syringe format. This is a firm fixed-price contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of October 21, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, fulfills this order as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Twinrix vaccine in syringe form, with a contract ceiling value of $4,948.52. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Twinrix vaccine in syringe form, with a ceiling value of $4,735.42 and an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Twinrix vaccine in syringe format, with a ceiling value of $17,246.08 and a firm fixed price structure. This non-competitive delivery order is set to conclude on May 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format, valued at $19,778.01 under a firm fixed-price contract type. The contract was competitively awarded with no set-aside designation and has an ultimate completion date of September 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which represents one of numerous pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $31,972.39 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This firm fixed price, competitively awarded contract was issued on October 21, 2025, with an ultimate completion date of October 22, 2025. The deliverables will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a...
- SPE2DR25D2012Indefinite Delivery Contract
- SPE2DR25D2012-SPE2DR26F1BHWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Twinrix vaccine in syringe form, with a ceiling value of $2,044.19 and an ultimate completion date of November 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products, medical devices, and vaccines to support military and veteran healthcare systems. This vaccine delivery order aligns with the company's extensive portfolio of federal medical supply contracts and demonstrates its ongoing role as a primary supplier within DLA's global pharmaceutical support network serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. No set-aside designation was applied to this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/5/25 |